HEADER TRANSFERASE 29-JAN-08 3C4F TITLE FGFR TYROSINE KINASE DOMAIN IN COMPLEX WITH 3-(3-METHOXYBENZYL)-7- TITLE 2 AZAINDOLE COMPND MOL_ID: 1; COMPND 2 MOLECULE: BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: FGFR-1, BFGF-R, FMS-LIKE TYROSINE KINASE 2, C-FGR, CD331 COMPND 6 ANTIGEN; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FGFR1, FGFBR, FLG, FLT2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)RIL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: VECTOR; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: PET29A KEYWDS FIBROBLAST GROWTH FACTOR RECEPTOR, TYROSINE KINASE DOMAIN, RECEPTOR KEYWDS 2 TYROSINE KINASE, FGFR1, FGFR, ALTERNATIVE SPLICING, ATP-BINDING, KEYWDS 3 CHROMOSOMAL REARRANGEMENT, DISEASE MUTATION, DWARFISM, GLYCOPROTEIN, KEYWDS 4 HEPARIN-BINDING, IMMUNOGLOBULIN DOMAIN, KALLMANN SYNDROME, MEMBRANE, KEYWDS 5 NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, POLYMORPHISM, TRANSFERASE, KEYWDS 6 TRANSMEMBRANE, TYROSINE-PROTEIN KINASE EXPDTA X-RAY DIFFRACTION AUTHOR K.Y.J.ZHANG,W.WANG REVDAT 5 21-FEB-24 3C4F 1 REMARK REVDAT 4 20-OCT-21 3C4F 1 REMARK SEQADV REVDAT 3 24-FEB-09 3C4F 1 VERSN REVDAT 2 18-MAR-08 3C4F 1 JRNL REVDAT 1 26-FEB-08 3C4F 0 JRNL AUTH J.TSAI,J.T.LEE,W.WANG,J.ZHANG,H.CHO,S.MAMO,R.BREMER, JRNL AUTH 2 S.GILLETTE,J.KONG,N.K.HAASS,K.SPROESSER,L.LI,K.S.SMALLEY, JRNL AUTH 3 D.FONG,Y.L.ZHU,A.MARIMUTHU,H.NGUYEN,B.LAM,J.LIU,I.CHEUNG, JRNL AUTH 4 J.RICE,Y.SUZUKI,C.LUU,C.SETTACHATGUL,R.SHELLOOE,J.CANTWELL, JRNL AUTH 5 S.H.KIM,J.SCHLESSINGER,K.Y.ZHANG,B.L.WEST,B.POWELL,G.HABETS, JRNL AUTH 6 C.ZHANG,P.N.IBRAHIM,P.HIRTH,D.R.ARTIS,M.HERLYN,G.BOLLAG JRNL TITL DISCOVERY OF A SELECTIVE INHIBITOR OF ONCOGENIC B-RAF KINASE JRNL TITL 2 WITH POTENT ANTIMELANOMA ACTIVITY JRNL REF PROC.NATL.ACAD.SCI.USA V. 105 3041 2008 JRNL REFN ISSN 0027-8424 JRNL PMID 18287029 JRNL DOI 10.1073/PNAS.0711741105 REMARK 2 REMARK 2 RESOLUTION. 2.07 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.25 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.07 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.5 REMARK 3 NUMBER OF REFLECTIONS : 40646 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.213 REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.264 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2167 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.07 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.12 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2939 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3050 REMARK 3 BIN FREE R VALUE SET COUNT : 184 REMARK 3 BIN FREE R VALUE : 0.3520 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4638 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 36 REMARK 3 SOLVENT ATOMS : 356 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.09 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.42000 REMARK 3 B22 (A**2) : 3.85000 REMARK 3 B33 (A**2) : -1.91000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.79000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.224 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.200 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.159 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.242 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.943 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.905 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4776 ; 0.014 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 4392 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6450 ; 1.592 ; 1.981 REMARK 3 BOND ANGLES OTHERS (DEGREES): 10252 ; 0.936 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 576 ; 3.196 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 702 ; 0.090 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5208 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 924 ; 0.003 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 989 ; 0.196 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 4954 ; 0.227 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): 2823 ; 0.084 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 291 ; 0.190 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 20 ; 0.194 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 104 ; 0.273 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 8 ; 0.168 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2896 ; 0.729 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4678 ; 1.354 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1880 ; 1.913 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1772 ; 3.213 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3C4F COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-JAN-08. REMARK 100 THE DEPOSITION ID IS D_1000046327. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-JUL-03 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.3.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 44044 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.050 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.0 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.10300 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 6.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.05 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.16 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.10 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.79300 REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CCP4 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.59 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.71 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 16% PEG10K, 0.3M (NH4)2SO4, 5% REMARK 280 ETHYLENE GLYCOL, 100 MM BIS-TRIS PH 6.5, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 104.09500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.81150 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 104.09500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 28.81150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1670 ANGSTROM**2 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 580 REMARK 465 LEU A 581 REMARK 465 GLU A 582 REMARK 465 TYR A 583 REMARK 465 CYS A 584 REMARK 465 TYR A 585 REMARK 465 ASN A 586 REMARK 465 PRO A 587 REMARK 465 SER A 588 REMARK 465 HIS A 589 REMARK 465 ASN A 590 REMARK 465 PRO A 591 REMARK 465 GLY B 580 REMARK 465 LEU B 581 REMARK 465 GLU B 582 REMARK 465 TYR B 583 REMARK 465 CYS B 584 REMARK 465 TYR B 585 REMARK 465 ASN B 586 REMARK 465 PRO B 587 REMARK 465 SER B 588 REMARK 465 HIS B 589 REMARK 465 ASN B 590 REMARK 465 PRO B 591 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O SER B 518 O HOH B 332 2.13 REMARK 500 OE1 GLU B 464 O HOH B 78 2.18 REMARK 500 OD1 ASP B 519 O HOH B 326 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP B 519 CB - CG - OD1 ANGL. DEV. = 5.5 DEGREES REMARK 500 ASP B 623 CB - CG - OD2 ANGL. DEV. = 5.4 DEGREES REMARK 500 ASP B 647 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 ASP B 753 CB - CG - OD2 ANGL. DEV. = 6.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 486 46.46 36.75 REMARK 500 ASP A 519 49.83 -101.98 REMARK 500 GLU A 593 118.29 -31.60 REMARK 500 ARG A 622 -17.47 84.79 REMARK 500 ASP A 623 52.07 -141.67 REMARK 500 TRP A 737 30.18 -95.55 REMARK 500 GLN A 764 -57.07 118.83 REMARK 500 LEU B 500 -74.38 62.25 REMARK 500 PRO B 505 7.13 -60.09 REMARK 500 ASP B 519 44.36 -93.44 REMARK 500 ARG B 622 -33.67 86.40 REMARK 500 ALA B 645 68.91 -107.59 REMARK 500 THR B 658 1.49 -63.79 REMARK 500 GLN B 764 -58.65 120.86 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE C4F A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE C4F B 2 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3C4C RELATED DB: PDB REMARK 900 B-RAF KINASE IN COMPLEX WITH PLX4720 REMARK 900 RELATED ID: 3C4D RELATED DB: PDB REMARK 900 B-RAF KINASE V600E ONCOGENIC MUTANT IN COMPLEX WITH PLX3203 REMARK 900 RELATED ID: 3C4E RELATED DB: PDB REMARK 900 PIM-1 KINASE DOMAIN IN COMPLEX WITH 3-AMINOPHENYL-7-AZAINDOLE DBREF 3C4F A 464 765 UNP P11362 FGFR1_HUMAN 464 765 DBREF 3C4F B 464 765 UNP P11362 FGFR1_HUMAN 464 765 SEQADV 3C4F ALA A 488 UNP P11362 CYS 488 ENGINEERED MUTATION SEQADV 3C4F ALA B 488 UNP P11362 CYS 488 ENGINEERED MUTATION SEQRES 1 A 302 GLU LEU PRO GLU ASP PRO ARG TRP GLU LEU PRO ARG ASP SEQRES 2 A 302 ARG LEU VAL LEU GLY LYS PRO LEU GLY GLU GLY ALA PHE SEQRES 3 A 302 GLY GLN VAL VAL LEU ALA GLU ALA ILE GLY LEU ASP LYS SEQRES 4 A 302 ASP LYS PRO ASN ARG VAL THR LYS VAL ALA VAL LYS MET SEQRES 5 A 302 LEU LYS SER ASP ALA THR GLU LYS ASP LEU SER ASP LEU SEQRES 6 A 302 ILE SER GLU MET GLU MET MET LYS MET ILE GLY LYS HIS SEQRES 7 A 302 LYS ASN ILE ILE ASN LEU LEU GLY ALA CYS THR GLN ASP SEQRES 8 A 302 GLY PRO LEU TYR VAL ILE VAL GLU TYR ALA SER LYS GLY SEQRES 9 A 302 ASN LEU ARG GLU TYR LEU GLN ALA ARG ARG PRO PRO GLY SEQRES 10 A 302 LEU GLU TYR CYS TYR ASN PRO SER HIS ASN PRO GLU GLU SEQRES 11 A 302 GLN LEU SER SER LYS ASP LEU VAL SER CYS ALA TYR GLN SEQRES 12 A 302 VAL ALA ARG GLY MET GLU TYR LEU ALA SER LYS LYS CYS SEQRES 13 A 302 ILE HIS ARG ASP LEU ALA ALA ARG ASN VAL LEU VAL THR SEQRES 14 A 302 GLU ASP ASN VAL MET LYS ILE ALA ASP PHE GLY LEU ALA SEQRES 15 A 302 ARG ASP ILE HIS HIS ILE ASP TYR TYR LYS LYS THR THR SEQRES 16 A 302 ASN GLY ARG LEU PRO VAL LYS TRP MET ALA PRO GLU ALA SEQRES 17 A 302 LEU PHE ASP ARG ILE TYR THR HIS GLN SER ASP VAL TRP SEQRES 18 A 302 SER PHE GLY VAL LEU LEU TRP GLU ILE PHE THR LEU GLY SEQRES 19 A 302 GLY SER PRO TYR PRO GLY VAL PRO VAL GLU GLU LEU PHE SEQRES 20 A 302 LYS LEU LEU LYS GLU GLY HIS ARG MET ASP LYS PRO SER SEQRES 21 A 302 ASN CYS THR ASN GLU LEU TYR MET MET MET ARG ASP CYS SEQRES 22 A 302 TRP HIS ALA VAL PRO SER GLN ARG PRO THR PHE LYS GLN SEQRES 23 A 302 LEU VAL GLU ASP LEU ASP ARG ILE VAL ALA LEU THR SER SEQRES 24 A 302 ASN GLN GLU SEQRES 1 B 302 GLU LEU PRO GLU ASP PRO ARG TRP GLU LEU PRO ARG ASP SEQRES 2 B 302 ARG LEU VAL LEU GLY LYS PRO LEU GLY GLU GLY ALA PHE SEQRES 3 B 302 GLY GLN VAL VAL LEU ALA GLU ALA ILE GLY LEU ASP LYS SEQRES 4 B 302 ASP LYS PRO ASN ARG VAL THR LYS VAL ALA VAL LYS MET SEQRES 5 B 302 LEU LYS SER ASP ALA THR GLU LYS ASP LEU SER ASP LEU SEQRES 6 B 302 ILE SER GLU MET GLU MET MET LYS MET ILE GLY LYS HIS SEQRES 7 B 302 LYS ASN ILE ILE ASN LEU LEU GLY ALA CYS THR GLN ASP SEQRES 8 B 302 GLY PRO LEU TYR VAL ILE VAL GLU TYR ALA SER LYS GLY SEQRES 9 B 302 ASN LEU ARG GLU TYR LEU GLN ALA ARG ARG PRO PRO GLY SEQRES 10 B 302 LEU GLU TYR CYS TYR ASN PRO SER HIS ASN PRO GLU GLU SEQRES 11 B 302 GLN LEU SER SER LYS ASP LEU VAL SER CYS ALA TYR GLN SEQRES 12 B 302 VAL ALA ARG GLY MET GLU TYR LEU ALA SER LYS LYS CYS SEQRES 13 B 302 ILE HIS ARG ASP LEU ALA ALA ARG ASN VAL LEU VAL THR SEQRES 14 B 302 GLU ASP ASN VAL MET LYS ILE ALA ASP PHE GLY LEU ALA SEQRES 15 B 302 ARG ASP ILE HIS HIS ILE ASP TYR TYR LYS LYS THR THR SEQRES 16 B 302 ASN GLY ARG LEU PRO VAL LYS TRP MET ALA PRO GLU ALA SEQRES 17 B 302 LEU PHE ASP ARG ILE TYR THR HIS GLN SER ASP VAL TRP SEQRES 18 B 302 SER PHE GLY VAL LEU LEU TRP GLU ILE PHE THR LEU GLY SEQRES 19 B 302 GLY SER PRO TYR PRO GLY VAL PRO VAL GLU GLU LEU PHE SEQRES 20 B 302 LYS LEU LEU LYS GLU GLY HIS ARG MET ASP LYS PRO SER SEQRES 21 B 302 ASN CYS THR ASN GLU LEU TYR MET MET MET ARG ASP CYS SEQRES 22 B 302 TRP HIS ALA VAL PRO SER GLN ARG PRO THR PHE LYS GLN SEQRES 23 B 302 LEU VAL GLU ASP LEU ASP ARG ILE VAL ALA LEU THR SER SEQRES 24 B 302 ASN GLN GLU HET C4F A 1 18 HET C4F B 2 18 HETNAM C4F 3-(3-METHOXYBENZYL)-1H-PYRROLO[2,3-B]PYRIDINE FORMUL 3 C4F 2(C15 H14 N2 O) FORMUL 5 HOH *356(H2 O) HELIX 1 1 PRO A 474 ASP A 476 5 3 HELIX 2 2 GLY A 485 ALA A 488 5 4 HELIX 3 3 THR A 521 GLY A 539 1 19 HELIX 4 4 ASN A 568 ARG A 576 1 9 HELIX 5 5 SER A 596 LYS A 617 1 22 HELIX 6 6 ALA A 625 ARG A 627 5 3 HELIX 7 7 ASP A 647 ILE A 651 5 5 HELIX 8 8 LEU A 662 MET A 667 5 6 HELIX 9 9 ALA A 668 ARG A 675 1 8 HELIX 10 10 THR A 678 THR A 695 1 18 HELIX 11 11 PRO A 705 GLU A 715 1 11 HELIX 12 12 THR A 726 TRP A 737 1 12 HELIX 13 13 VAL A 740 ARG A 744 5 5 HELIX 14 14 THR A 746 THR A 761 1 16 HELIX 15 15 PRO B 474 ASP B 476 5 3 HELIX 16 16 GLY B 485 ALA B 488 5 4 HELIX 17 17 THR B 521 GLY B 539 1 19 HELIX 18 18 ASN B 568 ALA B 575 1 8 HELIX 19 19 SER B 596 LYS B 617 1 22 HELIX 20 20 ALA B 625 ARG B 627 5 3 HELIX 21 21 LEU B 662 MET B 667 5 6 HELIX 22 22 ALA B 668 ASP B 674 1 7 HELIX 23 23 THR B 678 THR B 695 1 18 HELIX 24 24 PRO B 705 GLU B 715 1 11 HELIX 25 25 THR B 726 TRP B 737 1 12 HELIX 26 26 VAL B 740 ARG B 744 5 5 HELIX 27 27 THR B 746 LEU B 760 1 15 SHEET 1 A 5 LEU A 478 PRO A 483 0 SHEET 2 A 5 VAL A 492 ILE A 498 -1 O GLU A 496 N VAL A 479 SHEET 3 A 5 VAL A 508 LYS A 514 -1 O VAL A 513 N VAL A 493 SHEET 4 A 5 TYR A 558 GLU A 562 -1 O VAL A 561 N ALA A 512 SHEET 5 A 5 LEU A 547 CYS A 551 -1 N LEU A 548 O ILE A 560 SHEET 1 B 2 VAL A 629 VAL A 631 0 SHEET 2 B 2 MET A 637 ILE A 639 -1 O LYS A 638 N LEU A 630 SHEET 1 C 5 LEU B 478 PRO B 483 0 SHEET 2 C 5 GLN B 491 ILE B 498 -1 O LEU B 494 N LYS B 482 SHEET 3 C 5 VAL B 508 MET B 515 -1 O VAL B 511 N ALA B 495 SHEET 4 C 5 TYR B 558 GLU B 562 -1 O VAL B 561 N ALA B 512 SHEET 5 C 5 LEU B 547 CYS B 551 -1 N LEU B 548 O ILE B 560 SHEET 1 D 2 VAL B 629 VAL B 631 0 SHEET 2 D 2 MET B 637 ILE B 639 -1 O LYS B 638 N LEU B 630 SITE 1 AC1 7 PHE A 489 ALA A 512 GLU A 562 ALA A 564 SITE 2 AC1 7 LEU A 630 ALA A 640 ASP A 641 SITE 1 AC2 10 PHE B 489 ALA B 512 MET B 535 GLU B 562 SITE 2 AC2 10 TYR B 563 ALA B 564 LEU B 630 ALA B 640 SITE 3 AC2 10 ASP B 641 PHE B 642 CRYST1 208.190 57.623 65.368 90.00 107.62 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004803 0.000000 0.001525 0.00000 SCALE2 0.000000 0.017354 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016051 0.00000